Bone and Joint Health Supplements Market (By Product: Vitamins, Minerals, Collagen, Omega-3, Glucosamine, Others; By Formulation: Capsules, Tablets, Powders, Soft gels, Others; By Consumer Group: Infants, Children, Adults, Pregnant Women, Geriatric Population; By Sales Channel: Bricks and Mortar, E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global bone and joint health supplements market size was valued at USD 4.12 billion in 2023 and is anticipated to reach around USD 8.31 billion by 2033, growing at a CAGR of 7.27% from 2024 to 2033. The increasing prevalence of vitamin D deficiency, which results in osteoarthritis, encourages people to invest in preventive healthcare regimes, fuelling the growth of the market globally.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. bone and joint health supplements market size was estimated at USD 1.02 billion in 2023 and is predicted to be worth around USD 2.10 billion by 2033 with a CAGR of 7.48% from 2024 to 2033.
North America dominated the bone and joint health supplements market in 2023. The increasing number of people suffering from low bone density disorders and the rising geriatric population are the major driving factors of the North American region's market growth. In Canada, nearly 6 million people have been affected with bone and joint disorders, resulting in severe arthritis among these people, as per the report. Also, 37% of people are reported to use bone and joint health supplements on a regular basis due to the increased awareness about preventive care and the importance of multivitamins. A high prevalence of micronutrient deficiencies is also observed in people from the North American region, which encourages them to incorporate health supplements into their daily healthcare regime. These factors are further propelling the bone and joint health supplements market in North America, making it a dominant region in the globe.
Asia Pacific is expected to grow with the fastest CAGR during the forecast period. The growth of this region is attributed to the rising vitamin D deficiency in Asian people, which is notable, resulting in severe bone disorders like osteoporosis and arthritis, which have been observed among the people in this region. To increase the life span, people are aware of the positive impact of nutritional supplements on the human body and their correlation with longer life. Thus, rising awareness about healthcare supplements also fuels the market for bone and joint health supplements. Attracting the consumer key players in the market also comes with innovative formulations to target specific age groups people, and rising disposable income encourages people to invest more in their preventive health practices, which are the major reasons augmenting the bone and joint health supplements market growth in the Asia Pacific region.
The Asia Pacific bone and joint health supplements market size was calculated at USD 1.03 billion in 2023 and is projected to expand around USD 2.12 billion by 2033, poised to grow at a CAGR of 7.48% from 2024 to 2033.
Forecast Year | Market Size in USD |
2023 | $ 1.03 Billion |
2024 | $ 1.11 Billion |
2025 | $ 1.19 Billion |
2026 | $ 1.27 Billion |
2027 | $ 1.37 Billion |
2028 | $ 1.46 Billion |
2029 | $ 1.57 Billion |
2030 | $ 1.68 Billion |
2031 | $ 1.81 Billion |
2032 | $ 1.94 Billion |
2033 | $ 2.12 Billion |
Bone health ingredients, also referred to as bone health supplements, are utilized to support bone health. It aids in upkeep. The global bone and joint health supplements market is expected to grow most during the forecasted years. The rapidly growing geriatric population seeking to mitigate the pain that arises due to severe bone disorders like arthritis, which pose a challenge to move freely, is the major factor driving the bone and joint health supplements market growth.
The relieving fact is that people are becoming more aware of preventive healthcare practices and orthopedic disorders. Micronutrients are the essential and vital components of the human system; hence, they require a sufficient dose of such vital components to function without interruption caused by insufficient nutrition. Geriatric people are more susceptible to deficiencies due to age-related depletion in the human system; thus, they need to be more conscious about their health.
Report Coverage | Details |
Bone and Joint Health Supplements Market Size in 2023 | USD 4.12 Billion |
Bone and Joint Health Supplements Market Size in 2024 | USD 4.42 Billion |
Bone and Joint Health Supplements Market Size by 2033 | USD 8.31 Billion |
Bone and Joint Health Supplements Market Growth Rate | CAGR of 7.27% from 2024 to 2033 |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | Product, Formulation, Consumer Group, Sales Channel, and Regions |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Driver
Rising nutritional deficiency
The major driver of the bone and joint health supplements market is increasing nutritional deficiency among the geriatric and adult populations as well. Bad eating habits due to hectic lifestyles these days lead to restless activities and multitasking, which in turn manifest as various kinds of health disorders at a very young age. Along with this, overly used pesticides kill the nutritional value of vegetables, which come with fewer micronutrients. To defeat these challenges, people need to incorporate nutritional value-based supplements along with their daily meals to make up for the deficiency created by changing lifestyles.
Moreover, athletes are more susceptible to bone, muscle, and joint injuries. Therefore, they need to take proper preventive care by incorporating multivitamins and bone-strengthening supplements into their protein-rich diets to perform well. Hence, this also becomes an impacting factor, further propelling the bone and joint health supplements market globally.
Restraint
Cost of clinical trials
The significant restraining factor of the bone and joint health supplements market is the high cost of clinical trials for research and development of bone and joint health supplements, which holds utmost importance before launching any type of supplements in the market as it may have reverse effects on individuals' health as every person’s health history is different thus, way of responding to certain medications, even though its supplements may differ from one person to another. Hence, authorities have imposed stringent regulations on the research and development of new drugs or supplements from the healthcare sector, which may deter market growth due to either a lack of funding or may be due to high initial investments in the necessary settings to test the efficacy of newly developed drugs.
Opportunities
Personalized nutrition solutions
The major opportunity for the bone and joint health supplements market lies in the personalized nutrition solutions available in the market. Lifestyle changes these days encourage people to look after their health as most prior things due to the rising prevalence of bone and joint disorders caused by a sedentary lifestyle, lack of vitamin D, and less physical activity.
Digital health platforms and virtual care platforms augment the growth of the market as they provide counseling and tailored health supplements as per individuals' needs in the comfort of home without the need to visit clinics again, making it an easier option for people having hectic life schedules or people away from urban areas looking for nutritive solutions by their own.
Demand for organic and natural supplements
Moreover, there is a rising demand for organic and naturally derived herbal supplements from consumers worldwide. These supplements mostly contain naturally derived collagen, plant extracts, special herbs from particular regions, marine plant extract, etc. Thus, the bone and joint health supplements market is witnessing a surge in supplements based on herbal extract due to their innumerable benefits, holding the potential to create a lucrative opportunity in the foreseeable period.
The vitamins segment dominated the bone and joint health supplements market in 2023. The growth of this segment can be attributed to factors such as rising awareness about vital nutrients, including vitamins such as vitamin A, vitamin D, and C for healthy bones and joints, increased life expectancy, and an active lifestyle. Vitamins are the building blocks for the bones and joints; in particular, Vit D and K are linked with the higher density of bones, which mitigates the chances of getting fractures easily. Multivitamins play a significant role in the health of women after 40 years and pregnant women as they are prone to suffer from nutritional deficiency. Hence, the vitamin segment is propelled by people suffering from lower-density bone disorders, pregnant women, feeding mothers, and geriatric people.
The glucosamine segment is predicted to witness the fastest growth in the forecasted years. Glucosamine is specifically formulated to relieve joint pain, such as arthritis, based on studies that show the effectiveness of glucosamine in combating joint pain, including osteoarthritis. Due to its proven effectiveness, glucosamine is the main ingredient available as a medicinal substance in the UK and European countries.
Tthe capsules segment accounted for the largest share of the bone and joint health supplements market in 2023. Various encapsulation types are available for products in the healthcare market, including bone and joint health supplements. Capsules are easy to carry and have a longer shelf life, which does not affect key ingredients encapsulated by environmental changes, making them preferable to many consumers. Various vitamins, minerals, and omega-3 fatty acids are available in the multilayered capsule format, further driving global market growth.
The powders segment is expected to showcase the fastest CAGR in the upcoming years. The rising availability of powder formulation is responsible for this segment's growth. Powder formulation for vitamins is easy to use and better for digestive health as it's been able to dilute in the water, which might be slightly more effective than other formulations as per the body type of individual, and it comes with a longer shelf life owing to its airtight packaging method, that will act as a barrier from any harmful reactions by atmospheric changes. These factors propel the powder formulation segment’s bone and joint health supplements market growth.
The geriatric population segment dominated the bone and joint health supplements market in 2023. Geriatric people are the most vulnerable to bone and joint disorders as these disorders have slightly developed over the years without much notice by individuals, thus driving the growth of the market based on consumers' insights. Osteoporosis and osteoarthritis are two major yet frequently diagnosed bone disorders found in aged individuals on a larger scale.
Meanwhile, the adult segment is expected to grow with the fastest CAGR during the foreseeable period. The growth of this segment is attributed to the rising awareness about nutritional supplements and their positive effects from mid-age. According to the survey, around 18% of individuals aged between 18 and 34 years have found consuming bones and joint health supplements regularly, while 19% of consumers aged between 35 and 54 years do the same. Hence, the adult segment is increasing as per the consumer age group in the global bone and joint health supplements market.
The bricks and mortar segment dominated the bone and joint health supplements market in 2023. The availability of a rising number of retail stores that provide a range of health supplements, including bone and joint health supplements, with various well-established brands, is further fuelling this segment’s growth globally. Key market players were investing in retail stores to reach a maximum number of consumers and make available a variety of healthcare supplements as per their needs and affordability.
The e-commerce segment is expected to witness the fastest CAGR in the estimated years. This platform emerges as the most influential marketing strategy as it reaches the maximum geographical areas globally and provides home services, which is the key factor that propels the growth of the market. Hence, many healthcare suppliers collaborate with these online platforms to sell their products to the masses. Also, the rising preference for online shopping again fuels this segment's growth in the market.
Segments Covered in the Report
By Product
By Formulation
By Consumer Group
By Sales Channel
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Bone and Joint Health Supplements Market
5.1. COVID-19 Landscape: Bone and Joint Health Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Bone and Joint Health Supplements Market, By Product
8.1. Bone and Joint Health Supplements Market Revenue and Volume Forecast, by Product, 2024-2033
8.1.1. Vitamins
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Minerals
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Collagen
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Omega-3
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Glucosamine
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
8.1.6. Others
8.1.6.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Bone and Joint Health Supplements Market, By Formulation
9.1. Bone and Joint Health Supplements Market Revenue and Volume Forecast, by Formulation, 2024-2033
9.1.1. Capsules
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Tablets
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Powders
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Soft gels
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
9.1.5. Others
9.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Bone and Joint Health Supplements Market, By Consumer Group
10.1. Bone and Joint Health Supplements Market Revenue and Volume Forecast, by Consumer Group, 2024-2033
10.1.1. Infants
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Children
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Adults
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Pregnant Women
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Geriatric Population
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Bone and Joint Health Supplements Market, By Sales Channel
11.1. Bone and Joint Health Supplements Market Revenue and Volume Forecast, by Sales Channel, 2024-2033
11.1.1. Bricks and Mortar
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. E-commerce
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global Bone and Joint Health Supplements Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.1.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.1.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.1.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.1.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.1.5.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.1.5.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.1.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.1.6.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.1.6.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.2.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.2.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.2.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.2.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.2.5.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.2.5.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.2.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.2.6.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.2.6.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.2.7.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.2.7.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.2.7.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.2.8.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.2.8.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.2.8.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.3.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.3.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.3.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.3.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.3.5.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.3.5.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.3.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.3.6.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.3.6.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.3.7.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.3.7.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.3.7.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.3.8.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.3.8.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.3.8.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.4.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.4.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.4.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.4.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.4.5.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.4.5.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.4.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.4.6.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.4.6.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.4.7.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.4.7.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.4.7.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.4.8.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.4.8.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.4.8.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.5.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.5.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.5.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.5.5.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.5.5.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.5.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
12.5.6.3. Market Revenue and Volume Forecast, by Consumer Group (2021-2033)
12.5.6.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
Chapter 13. Company Profiles
13.1. Herbalife International of America, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. GNC Holdings, LLC
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Nature's Bounty
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. BYHEALTH Co., Ltd.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Amway
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. BASF SE
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Bayer AG
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Vitalife Ltd
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Glanbia plc
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. NOW Foods
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client